Analysis of different <scp>HER</scp>‐2 mutations in breast cancer progression and drug resistance
Analysis of different <scp>HER</scp>‐2 mutations in breast cancer progression and drug resistance is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Analysis of different <scp>HER</scp>‐2 mutations in breast cancer progression and drug resistance have?
Analysis of different <scp>HER</scp>‐2 mutations in breast cancer progression and drug resistance has 61 citations in the OpenAlex counts ScholarIQ stores.
When was Analysis of different <scp>HER</scp>‐2 mutations in breast cancer progression and drug resistance published?
Analysis of different <scp>HER</scp>‐2 mutations in breast cancer progression and drug resistance has 2015 year in the ScholarIQ index.
What is the open-access status of Analysis of different <scp>HER</scp>‐2 mutations in breast cancer progression and drug resistance?
Analysis of different <scp>HER</scp>‐2 mutations in breast cancer progression and drug resistance has gold oa status in the ScholarIQ index.
What is the DOI of Analysis of different <scp>HER</scp>‐2 mutations in breast cancer progression and drug resistance?
The DOI for Analysis of different <scp>HER</scp>‐2 mutations in breast cancer progression and drug resistance is on the source record.
What is the PMID of Analysis of different <scp>HER</scp>‐2 mutations in breast cancer progression and drug resistance?
The PMID for Analysis of different <scp>HER</scp>‐2 mutations in breast cancer progression and drug resistance is on the source record.
What is the OpenAlex record for Analysis of different <scp>HER</scp>‐2 mutations in breast cancer progression and drug resistance?
The OpenAlex for Analysis of different <scp>HER</scp>‐2 mutations in breast cancer progression and drug resistance is on the source record.